Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13
Item hits:
Issue DateTitleAuthor(s)
13-Jun-2014Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal CancerKrell, J; Frampton, AE; Mirnezami, R; Harding, V; De Giorgio, A, et al
15-Aug-2016MicroRNAs associated with small bowel neuroendocrine tumours and their metastasesMiller, HC; Frampton, AE; Malczewska, A; Ottaviani, S; Stronach, EA, et al
Jan-2021Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19Sims, JT; Krishnan, V; Chang, C-Y; Eagle, SM; Casalini, G, et al
25-Jan-2017Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFRCastellano, L; Dabrowska, A; Pellegrino, L; Ottaviani, S; Cathcart, P, et al
10-May-2018TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionOttaviani, S; Stebbing, J; Frampton, A; Zagorac, S; Krell, J, et al
10-May-2018TGF-beta induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionOttaviani, S; Stebbing, J; Frampton, AE; Zagorac, S; Krell, J, et al
1-Jan-2021JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityStebbing, J; Nievas, GS; Falcone, M; Youhanna, S; Richardson, P, et al
18-Dec-2020What is the best drug to treat COVID-19? The need for randomized controlled trialsOttaviani, S; Stebbing, J;
2-May-2020CNS penetration of potential anti-COVID-19 drugs.Richardson, PJ; Ottaviani, S; Prelle, A; Stebbing, J; Casalini, G, et al
31-Jul-2020A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.Peng, L; Xiao, K; Ottaviani, S; Stebbing, J; Wang, Y-J, et al